Article

Researchers Identify Rules That Govern Immune Response

Author(s):

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.

The research, led by Gerard C. L. Wong, professor of bioengineering and chemistry, UCLA, UCLA’s Henry Samueli School of Engineering and Applied Science, and California NanoSystems Institute, was published in the journal Nature Materials.

Using synchrotron X-ray scattering and other methods, the researchers “determined that a broad range of molecules, both organic and inorganic, can organize self-DNA into a liquid crystalline structure that binds strongly” to TLR9 receptors, which induce the interferon response.

This crystalline structure protects the DNA, thus strengthening the immune response.

If researchers can learn more about how these molecules are organized, it could pave the way for more effective treatments for lupus, psoriasis, and other autoimmune disorders.

Wong commented, “Our research has identified a set of rules that tell us what types of molecules or materials can set off this aspect of the immune system. This new knowledge will make it easier to design new therapeutic strategies to control immune responses.”

Furthermore, Nathan Schmidt, another study author, said, “Our colleagues had established empirically that certain molecules were activating self-DNA and triggering responses in disorders such as lupus and psoriasis. We were able to elucidate something that was poorly understood — a key to triggering the immune response is that the molecules must arrange the DNA so that the receptors bind to them strongly.”

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
© 2024 MJH Life Sciences

All rights reserved.